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Abstract 
Cancer is considered one of the most serious diseases that threaten the society at present. Accordingly, some 
antioxidants have been studied about breast cancer during chemotherapy and the effect of this treatment on 
antioxidants that protect cells from oxidation and damage associated with cancer. This study was conducted on 
(92) Participants; (52) of which for patients with breast cancer who are aged between (25-80) year. Additionally, 
(40) healthy people aged between (22-75) year were enrolled. The samples were obtained from the Center for 
Oncology in Azadi Teaching Hospital in Kirkuk. This research deals with the study of glutathione peroxidase 
(GPx) using gel filtration (Sephadex-50) and the dimension column (28×1.5) cm. The serum from a patient with 
breast cancer was partially purified and compared with that from healthy female control. The effect of 
chemotherapy on GPx, Catalase (CAT), Glutathione (GSH) and Uric acid (U. A) has studied as an antioxidant. 
The results showed, A substantial decrease in the catalase enzyme in the different groups of chemical doses  (A, 
B, C and D) Group (A) consists of patients undergoing chemotherapy from (1-3) Chemotherapy doses. Group 
(B) consists from (4-6) Chemotherapy doses, Group (C) consists from (7-9) Chemotherapy doses, Group (D) 
consists from (10-12) Chemotherapy doses at a Statistical level (p ≤0.01). On the other hand, the group (E) 
consists from (13-16) Chemotherapy doses has found no considerable difference, the drugs that make up the 
chemotherapy given  to patients (Adriamycin, Cytoxan, methotrexate, Fluorouracil). the level of enzyme activity 
(GPx)   at a Statistical level (p ≤0.01). (C, D and E) groups is decrease, either groups represented by (A and B)  
with no significant difference was recorded, the level of enzyme activity (GSH) at a Statistical level (p ≤0.01).  
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(A) group is decrease, either groups represented by (B,C,D,E) groups  with no significant difference was 
recorded,.Lastly, in the Uric acid, there are No significant differences in groups that differ in chemical doses. 
Keywords: Breast cancer; Glutathione peroxidase; Glutathione; Catalase; Uric acid; Purification of glutathione 
peroxidase; chemotherapy. 
1. Introduction  
Breast cancer is one of the most serious diseases affecting the society. This research is due to the spread of this 
disease in our societies. This research investigates the effect of chemotherapy given to breast cancer patients and 
its effect on the body enzymes that act as antioxidants. 
Cancer is a disease caused by abnormal divisions of the cells of the body in a disorderly and unstructured [1]. 
Each organ in the human body consists of a group of cells that suffer from limited and regular divisions and 
under full control to compensate for the shortage of damaged cells and maintain the body in a healthy manner 
[2]. Therefore, any disorder that occurs in the divisions of these cells leads to a defect in the size of the cell. 
Consequently, a breach occurs in the system of regular division of the cell [3], and hence starts the tumor as a 
result of the production of cells that do not need the member [1]. 
1.1 The Breast Cancer   
 It is a complex disease that requires mutual awareness between both doctors and patients [4] It’s the most 
common disease in women with 1 out of every 9 women who are at risk of developing breast cancer [5]. Men 
may also suffer for every 200 infection in women there is one infection for men [6]. Breast cancer is a malignant 
disease in the form of a tumor that arises from the breast cells itself, and most cases of the breast cancer start 
from the small ducts [7]. 
1.2 Chemotherapy and Breast Cancer 
 It is a group of drugs used to get rid of cancer cells. They are given directly to the bloodstream and reach all 
parts of the body [8]. Therefore, it is the best treatment for the patient who suffers from the spread of the disease 
throughout the body [9]. Chemotherapy is given for breast cancer in the following cases: 
• In the event of the spread of the disease throughout the body [10]. 
• Reduces the size of the tumor before the operation, which facilitates the tumor removal agent in the 
case of response of the tumor to the drug and its smaller size became. However, in the case of no size 
changes, this indicates the lack of response and the drug must be changed [11] 
• After the mastectomy, chemotherapy doses are given to reduce tumor recurrence [12]. 
1.3 Breast Cancer and Oxidative Stress      
An imbalance between effective free radicals and the antioxidant defense system[13]. It is known that free 
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radicals are ions, atoms or molecules containing one or more single electrons that give them high efficiency to 
interact with another free radical or molecule to reach stability [14]. These free radicals act on oxidation of cell 
membranes and important molecules within them (such as DNA, proteins and fats) causing significant damage 
to these molecules [15]. Causing significant damage to these molecules, evidence suggests the participation of 
free radicals in the transformation of cells of the body into cancer cells, which have a significant role in the 
process of development and formation of cancer cells[16]. 
1.4 Glutathione Peroxidase-Enzyme      
 The primary Function of GPx is to counteract the oxidative attack [17]. It is classified into oxidation and 
reduction enzymes (E.C.1.11.1.9) [18]. Selenium element (Selenium-Se) plays a significant role in the 
concentration of peroxidase in the body because it is the main component of peroxidase [19]. There are many 
proteins in mammalian cells that can metabolize peroxide and lipid hydroxyl oxides. These include selenium-
four proteins found in various cells and tissues in the body, and selenium can be obtained from the nutrient-rich 
in this element. The peroxidase is Subcutaneous protein units, each of which has one atom of selenium (Se) and 
is associated with cysteine. The total Molecular weight of the peroxidase is 44000 daltons [20]. 
1.5 Purification of glutathione peroxidase 
The enzyme peroxidase is an essential and necessary enzyme that keeps the cell safe from damage and various 
diseases. The techniques used in the purification of this enzyme are gel filtration chromatography, and ion 
exchange Chromatography as well as membrane screening Dialysis[21]. In the purification process, chemicals 
are used to separate the enzymes based on the molecular weight and size of the constituent molecules[22]. The 
chemicals used in the separation process are Sephadex  and (DEAE-cellulose) [23]. Then, deposition of the 
enzyme by the precipitates [24]. 
2. Materials and Methods 
2.1 Sample of study 
The study was conducted on (92) blood samples (52) for patients with breast cancer and (40) for healthy ones. 
The samples were obtained from the Center of Oncology / Azadi Teaching Hospital / Kirkuk. The patients 
ranged between (25-80) years To be subject to chemotherapy sessions, while for healthy people ranged between 
(22-75) years. Samples were collected from 1/2/2017 to 28/5/2017, The chemotherapy doses given to patients 
with breast cancer begin with (1-16) Chemotherapy doses, and the patients were divided into five groups 
according to the different chemical doses given to them,Group (A) consists of (1-3) Chemotherapy doses. Group 
(B) consists from (4-6) Chemotherapy doses, Group (C) consists from (7-9) Chemotherapy doses, Group (D) 
consists from (10-12) Chemotherapy doses at a Statistical level (p ≤0.01). On the other hand, the group (E) 
consists from (13-16) Chemotherapy doses, The drugs that make up the chemotherapy given  to patients 
(Adriamycin, Cytoxan, methotrexate, Fluorouracil). 
2.2 Blood Samples Collection and Serum Preparation 
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Blood samples were collected by drawing blood from the vein using a disposable syringe with a thin lid (5 
cm3). Blood was placed in plastic tubes that did not contain anticoagulants,The tubes were left at laboratory 
temperature until coagulated and then centrifuged for 10 minutes and at a speed of 4000 rpm. After the serum 
separation, it was withdrawn by a micro-pipette until the tests are carried out. Lastly, (-20C0) dry, clean and 
sterile tubes and kept in a freezing state. 
2.3 Determination of the Activity of Catalase in Serum 
The activity of the catalase enzyme is estimated Spectrometrically at a wavelength of (240 nm). The 
concentration of this enzyme depends on the consumption of hydrogen peroxide [25]. 
2.4 Determination of the Activity of Glutathione  Peroxidase  in Serum 
The activity of the Gpx enzyme was estimated using the chromatic method on Green and Hill [26]. 
2.5 Determination of the Activity of Glutathione in Serum 
The concentration of glutathione in blood plasma was measured by DTNB (Ellman’s Reagent). Different 
disulfides are formed and the thiol anion when the compound was combined with the thiol group (SH) in the 
glutathione molecule in a basal medium (pH = 8). These have measured by the spectrophotometer at a 
wavelength of (420 nm) [27]. 
2.6 Determination of  the Concentration of  Uric Acid   in Serum 
Uric acid is oxidized by the urease enzyme to the Aerosol compound and hydrogen peroxide is released, which 
indicates the oxidation of (4-2 dichlorophenol) complex  by the peroxidase enzyme and the presence of the 
colored solution)[28]. 
2.7 Purification of Glutathione Peroxidase 
Glutathione Pyroxidase is purified by gel filtration chromatography technique, which is one of the techniques 
that depends on the molecular size and molecular weights, I use a (28 x 1.5 cm) thick column that contains the 
(DEAE Sephadex-50) gel which separates the compounds based on the size. The gel is placed at a height of 20 
cm by pouring the gel on the walls of the column of the separation quietly and obliquely to prevent the 
formation of the bubbles, After placing an appropriate piece of glass wool at the end of the column, The blood 
serum was injected into the column of the separation in a circular manner and on the columns of the separation 
column followed by the procedure of the Rogan using the regulated solution with pH 7. The process was 
collected at a rate of (65.4 cm3 /  hour) ,( 1.09 cm3/ per minute) and manually. Calculation of the protein 
concentration by measuring the absorbance of the separated parts, and using the fulen method as in the above 
paragraph. In addition, the efficacy of Glutathione Peroxidase was monitored in each of the separated parts [29]. 
2.8 Statistical Analysis 
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The results were statistically analyzed using (ANOVA). The results showed by the mean values of (Mean ± 
SD). The (F-TEST) test was used to compare groups to analyze the results of patients with breast and healthy 
cancer, divided by the number of chemical doses assigned to each patient, Graphs were drawn using (Minitab 
ver) (2017) 
3. Results and Discussion 
3.1 The Results 
Results showed a substantial decrease of the catalase enzyme in the different groups of chemical doses (A,  B, C 
and D). However, in the (E) group, no significant difference was recorded at a Statistical level (p ≤0.01) (There 
is no significant difference in E group only) so in the statistical analysis shows that there is a significant change 
meant for the rest of the groups and not E group 
. These results are listed in the Table (1). 
Table 1: The average standard deviation shows the level of antioxidant enzymes according to difference in 
chemotherapy doses 
Parameters 
Patients / 
n=11 
Group (A) 
(1-3) 
Patients / 
n=15 
Group (B) 
(4-6) 
Patients / 
n=12 
Group (C) 
(7-9) 
Patients / 
n=4 
Group (D) 
(10-12) 
Patients / 
n=10 
Group (E) 
(13-16) 
P≤ 
 
CAT (k/ml) 0.389 ±0.035 0.367±0.012 0.302±0.012 0.257±0.003 0.235±0.019 0.01 
GPx (U/l) 0.3925±0.02316 0.38500±0.01883 0.33133±0.01876 0.276±0.012 0.198±0.010 0.01 
U.A (mg/dl) 5.527±0.919 6.683±1.267 7.460±3.78 7.300±1.134 6.750±1.182 N.S 
GSH 
(µmol/L) 
4.568±0.239 3.852±0.280 3.660±0.219 2.717±0.047 2.7940±0.273 0.01 
 
* Chemotherapy is given to patients with breast cancer only, so there is no healthy groups in this table 
Additionally, for glutathione peroxidase, it showed significant decrease at a Statistical level (p ≤0.01) in totals 
that vary in chemical doses and include these totals (C, D and E)  either group represented by (A and B). 
Therefore, as shown in the Table (1), no significant difference was recorded. When moving from group A to 
group B did not notice any significant difference in the effectiveness of the enzyme as for the rest of the groups 
found a significant difference in the effectiveness of the enzyme. 
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Consequently, the results showed a significant decrease in the level of enzyme efficacy (GSH)  at a Statistical 
level (p ≤0.01). In a group that varies by chemical dose is the group (A) as groups (B, C, D and E)  no 
significant difference was recorded. Meanwhile, the results of uric acid showed that there are no significant 
differences at a Statistical level (p ≤0.01) in groups that differ in chemical doses.  
As for the purification of glutathione peroxidase enzyme, the results were shown in the Figure (1), a single peak 
of the purified enzyme with a capacity of 0.367 units / l in patients with breast cancer. The same enzyme value 
was (0.266) units/litre for the healthy control group (gm/cm3), which represents the highest amount of protein in 
the serology of patients with breast cancer. 
2.  
Figure 1: glutathione peroxidase enzyme and concentration of protein from the separation column using Gel 
filtration chromatography using (DEAE Sephadex) for the sample (G2) 
Table 2: Purification of glutathione peroxidase in the serum of a woman with breast cancer using gel filtration 
chromatography. 
Steps 
Total 
Volume 
(ml) 
Protein  
conc. 
mg/ml 
Total 
protein 
conc. 
mg/ml 
Activity 
U/L 
Total 
Activity 
x U/L 
specific 
activity 
U/mg 
Degree of 
purification 
Yield 
% 
Crude 
enzyme 
1 3.84 3.84 0.421 0.421 0.109 1 100 
Purified 
Enzyme 
1.5 3.21 4.815 0.367 0.550 0.114 1.045 130.6 
3.2 Discussion 
For catalase enzyme, studies have shown that cancer of all types increases the stress and as survival rates are 
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still weak there is an urgent need to develop treatments and make them more effective[30], breast tumors work 
to increase oxidative stress and must be matched by enough antioxidants to protect[31]. The Previous studies 
showed` that an increase in the secretion of antioxidant catalase may control the spread of the tumor [32]. The 
level of catalase has been measured in combination with chemotherapy. The most paramount drugs included in 
the synthesis of chemotherapy are (Cisplatin, 5-Fluorouracil, paclitaxel , Daunorubicin  &  Hydroxyurea ) [33]. 
Several studies have indicated that most chemotherapy works on the production of hydrogen peroxide and 
therefore the body needs to produce an increase of the catalase enzyme to get rid of the peroxide [34] . Thus, the 
above results show that the catalase enzyme starts to decrease as a result of increased peroxide [35], as well as 
studies have shown that cisplatin with catalase can eliminate cancer cells and prevent them from spreading [36]. 
As for the glutathione peroxidase enzyme,  the results can be explained by the fact that chemotherapy works on 
the reduction of reduced glutathione and enzyme-based antioxidant glutathione peroxidase, which may be the 
result of high oxidation after       chemotherapy. Free radicals increase and oxidative stress increases, causing 
significant and significant reduction in enzymatic antioxidants[37]. These enzymes protect the cells from 
harmful substances by stimulating their association with the reduced glutathione and prevent damage caused by 
the reactive oxygen species by reducing hydrogen peroxide, fat and phospholipid hydroperoxides, GPx 
works  together with the associated enzymes as an antioxidant for reduced glutathione, acts as a high level of 
glutathione peroxidase in most studied human cancers but decreases after chemotherapy. This is confirmed by 
(Moutet) and others [38]. 
The non - significant reduction in glutathione is due to the increased oxidative stress that leads to(NADPH). 
Increased glutathione oxidation reduces its level and can overcome this oxidation through the production which 
acts as an adjunct to the elimination of oxidized glutathione. This study was agreed with (Jayasurya and others) 
[39]. (Zhang and his colleagues) [40] confirmed that the level of concentration of glutathione might be a 
predictive sign of the patient's response to treatment and its success. The lower enzyme activity indicated its 
increased consumption due to increased oxidative stress [41]. 
Several studies have confirmed that uric acid may rise due to oxidative stress or some inflammation but is not 
affected by chemotherapy [42-43]. Glutathione peroxidase was partially purified from the blood vessels of 
patients with breast cancer and healthy by using gelatin filtration technique. The Glutathione peroxidase was 
separated depending on the difference in their size. Large particles pass first through the column because they 
move between the granules of the gel. The small particles penetrate into the molecules, and the gel is delayed by 
degeneration [44]. As shown in the Figure (1), (DEAE Sephadex -50) is used as a molecular sugar, which acts 
as a molecular molecule through which different proteins can be separated by molecular weight and by the 
presence of a phosphate-regulated phosphate solution (PH= 7) [45]. 
4. Recommendation 
Purification of glutathione peroxidase enzyme and isolation using other vital techniques such as ion exchange 
and other purifications for high purity.Studying the impact of drugs on the enzyme partially purified for patients 
with breast cancer.Inspecting the effect of chemotherapy and the damage done by the treatment of healthy cells 
in the body.Examining the influences of enzymatic antioxidants in the patients with breast cancer (Glutathione 
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S-transferases, Superoxide dismutase). Furthermore, studying the relationship between them and the enzyme 
glutathione peroxidase.and Conducting further studies on the enzyme purified molecule by using it by using it 
against different types of diseases.Determination of Trace elements that are included in the composition of 
antioxidants, such as selenium which is considered as the main component of the enzyme glutathione 
peroxidase. 
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